Journal profile · Pathology
Histopathology
ISSN 0309-0167 · eISSN 1365-2559 · Wiley-Blackwell Publishing Ltd · ENGLAND · Monthly · Founded 1977
Histopathology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.81; hybrid open access; APC about USD 4,840; median 84 days to acceptance (77 articles, last 24 months); community-reported acceptance: fairly easy; 265 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Histopathology is published by Wiley-Blackwell Publishing Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Lymphoma Diagnosis and Treatment and Breast Lesions and Carcinomas, together about 23.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Histopathology is an international journal intended to be of practical value to surgical and diagnostic histopathologists, and to investigators of human disease who employ histopathological methods. Our primary purpose is to publish advances in pathology, in particular those applicable to clinical practice and contributing to the better understanding of human disease.
Source: LetPub
Research area (LetPub): Pathology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine8.6%
- Lymphoma Diagnosis and TreatmentMedicine8.1%
- Breast Lesions and CarcinomasMedicine6.5%
- Cancer and Skin LesionsMedicine5.9%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology5.3%
- Salivary Gland Tumors Diagnosis and TreatmentMedicine5.3%
- Ovarian cancer diagnosis and treatmentMedicine4.8%
- Viral-associated cancers and disordersMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 2 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 2 |
| Minor | Pathology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cell Biology | Zone 2 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.81LetPub ·
- CiteScore 2026-06
- 7.7LetPub ·
- SJR 2026-06
- 1.67LetPub ·
- SNIP 2026-06
- 1.88LetPub ·
- h-index
- 111LetPub ·
- h-index
- 190OpenAlex ·
- i10-index
- 7,027OpenAlex ·
- 2-year mean citedness
- 3.24OpenAlex ·
- Self-citation rate
- 5.3%LetPub ·
- Share of gold OA articles
- 47.08%LetPub ·
Volume
- Articles per year
- 152LetPub ·
Articles by year OpenAlex count · 12,008 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 209 | 108 | 71 |
| 2025 | 265 | 167 | 688 |
| 2024 | 296 | 199 | 1,738 |
| 2023 | 280 | 185 | 2,410 |
| 2022 | 259 | 98 | 3,329 |
| 2021 | 302 | 109 | 4,018 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
84 daysMedian, submission to acceptance · P25–P75 63 days – 125 days
- Acceptance to online
- median 17 days (80 articles)
- Submission to online
- median 106 days
- Sample
- 77 articles with submission and acceptance dates (537 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,840 / EUR 4,070 / GBP 3,240 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1977
- ISSN
- 0309-0167
- Electronic ISSN
- 1365-2559
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Histopathology
What CAS zone is Histopathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Histopathology is in Zone 2 of Medicine, and in Zone 2 of the minor category Cell Biology / Pathology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Histopathology?
The latest impact factor listed by LetPub is 3.81; CiteScore 7.7, h-index 190.
How long does peer review take at Histopathology?
Based on the dates recorded on 77 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 84 days (interquartile range 63–125 days); authors report an average review time of about 1 month; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Histopathology?
According to LetPub and DOAJ records, Histopathology is indexed in SCIE and Scopus.
Is Histopathology open access, and what is the APC?
Histopathology is a hybrid journal. For open-access publication: APC about USD 4,840.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .